Transwel 180 & 360 180mg, 360mg Tablet
PDF Leaflet Revision Date: 9 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of acute organ transplant rejection in renal transplant patients.
Dosage (summary)
720 mg (four 180 mg or two 360 mg tablets) twice daily.
Special Populations
- Elderly
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; teratogenic effects noted.
Key Drug Interactions
- Acyclovir
- Cholestyramine
- Antacids
- Azathioprine
- Rifampicin
Contraindications
- Hypersensitivity to mycophenolic acid
- Pregnancy
- Lactation
Common side effects
- Infections
- Diarrhoea
- Fatigue
- Headache
- Neutropenia
Counselling Points
- Use effective contraception
- Report infections or bleeding
- Avoid live vaccines
Serious warnings
- Carcinogenicity
- Teratogenicity
- Increased infection risk
Important Disclaimer
The Transwel 180 & 360 180mg, 360mg Tablet professional information leaflet below is the property of Alkem Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
